Jordi Sierra

发表

GVHD prophylaxis with sirolimus-tacrolimus may overcome the deleterious effect on survival of HLA mismatch after reduced-intensity conditioning allo-SCT

C. Solano, J. Pérez-Simón, R. Martino, 2015, Bone Marrow Transplantation.

Mouth-washings with recombinant human granulocyte–macrophage colony stimulating factor (rhGM-CSF) do not improve grade III–IV oropharyngeal mucositis (OM) in patients with hematological malignancies undergoing stem cell transplantation. Results of a randomized double-blind placebo-controlled study

M. Sanz, A. Sureda, D. Valcárcel, 2002, Bone Marrow Transplantation.

Evaluation of prognostic factors among patients with chronic graft-versus-host disease

J. Miguel, J. Pérez-Simón, M. Remberger, 2012, Haematologica.

Incidence, characteristics and risk factors of marked hyperbilirubinemia after allogeneic hematopoietic cell transplantation with reduced-intensity conditioning

J. Pérez-Simón, R. Martino, I. Campos-Varela, 2012, Bone Marrow Transplantation.

High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative Group.

A. F. Sevilla, J. Garcia-conde, J. Sierra, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Patterns of infection and infection-related mortality in patients with steroid-refractory acute graft versus host disease

J. Briones, S. Brunet, R. Martino, 2017, Bone Marrow Transplantation.

On the reliability of clinical criteria for the diagnosis of hepatic veno-occlusive disease

A. Grañena, J. Sierra, M. Navasa, 1993, Annals of Hematology.

Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working party

G. Mufti, N. Kröger, M. Robin, 2017, Bone Marrow Transplantation.

Iron overload might increase transplant-related mortality in haematopoietic stem cell transplantation

J. Briones, S. Brunet, R. Martino, 2002, Bone Marrow Transplantation.

Lower respiratory tract respiratory virus infections increase the risk of invasive aspergillosis after a reduced-intensity allogeneic hematopoietic SCT

J. Briones, J. Delgado, S. Brunet, 2009, Bone Marrow Transplantation.

Effects of G-CSF administration and peripheral blood progenitor cell collection in 20 healthy donors

J. Briones, E. Montserrat, J. Sierra, 1996, Annals of Hematology.

Autologous stem cell transplantation for primary refractory Hodgkin's disease: results and clinical variables affecting outcome.

J. Garcia-conde, M. Terol, F. Hernández-Navarro, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Cytomegalovirus infection and disease after reduced intensity conditioning allogeneic stem cell transplantation: single-centre experience

R. Martino, N. Margall, N. Rabella, 2010, Bone Marrow Transplantation.

Chimerism analysis following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning

J. Pérez-Simón, R. Martino, J. Bargay, 2003, Bone Marrow Transplantation.

Does reduced-intensity allogeneic transplantation confer a survival advantage to patients with poor prognosis chronic lymphocytic leukaemia? A case-control retrospective analysis.

J. Briones, J. Delgado, J. Sierra, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Allogeneic stem cell transplantation with reduced-intensity conditioning is potentially feasible as an outpatient procedure

S. Brunet, R. Martino, A. Sureda, 2003, Bone Marrow Transplantation.

Hematopoietic transplantation from adult unrelated donors as treatment for acute myeloid leukemia

S. Brunet, R. Martino, D. Valcárcel, 2008, Bone Marrow Transplantation.

Low transplant-related mortality after second allogeneic peripheral blood stem cell transplant with reduced-intensity conditioning in adult patients who have failed a prior autologous transplant

R. Martino, J. Miguel, Á. Urbano-Ispizua, 2002, Bone Marrow Transplantation.

Impact of Epstein Barr virus-related complications after high-risk allo-SCT in the era of pre-emptive rituximab

J. Briones, S. Brunet, R. Martino, 2015, Bone Marrow Transplantation.